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Neuroimaging is a key element in the management of patients suffering from subarachnoid haemorrhage (SAH).
In this article, we review the current literature to provide a summary of the existing neuroimaging methods
available in clinical practice. Noncontrast computed tomography is highly sensitive in detecting subarachnoid
blood, especially within 6 hours of haemorrhage. However, lumbar puncture should follow a negative noncontrast
computed tomography scan in patients with symptoms suspicious of SAH. Computed tomography angiography is
slowly replacing digital subtraction angiography as the first-line technique for the diagnosis and treatment planning
of cerebral aneurysms, but digital subtraction angiography is still required in patients with diffuse SAH and negative
initial computed tomography angiography. Delayed cerebral ischaemia is a common and serious complication
after SAH. The modern concept of delayed cerebral ischaemia monitoring is shifting from modalities that measure
vessel diameter to techniques focusing on brain perfusion. Lastly, evolving modalities applied to assess cerebral
physiological, functional and cognitive sequelae after SAH, such as functional magnetic resonance imaging or
positron emission tomography, are discussed. These new techniques may have the advantage over structural
modalities due to their ability to assess brain physiology and function in real time. However, their use remains
mainly experimental and the literature supporting their practice is still scarce.Introduction
Aneurysmal subarachnoid haemorrhage (SAH) is caused
by the rupture of an intracranial aneurysm, which leads
to the extravasation of blood under high pressure into the
subarachnoid space. SAH triggers a cascade of events that
can result in death or severe disability. Poor outcomes are
not uncommon, and are typically due to early brain injury
associated with the initial haemorrhage or are secondary
to delayed cerebral ischaemia (DCI) and cerebral infarc-
tion. This review will focus on the clinical applicability of
neuroradiological tools applied to the diagnosis and man-
agement of SAH, angiographic cerebral vasospasm (ACV),
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(http://creativecommons.org/publicdomain/zeroSearch strategy and selection criteria
A PubMed search for articles published in English until
April 2014 was performed using the terms ‘subarachnoid
hemorrhage [All Fields] OR subarachnoid haemorrhage
[All Fields] OR cerebral aneurysm [All Fields] OR vaso-
spasm [All Fields] OR cerebral vasospasm [All Fields] OR
delayed cerebral ischemia [All Fields]’, which returned
84,357 articles (Additional file 1: Table S1). These articles
were further distilled via prospective and retrospective
studies, review articles, and meta-analyses addressing im-
aging features of SAH, and their reference lists were also
searched. The articles judged to be clinically relevant by
the authors were selected. The methodological quality of
the meta-analyses reviewed was assessed by the AMSTAR
tool (Additional file 1: Table S2) [1]. Additionally, the refer-
ences from the authors’ personal database were retrieved
and also used as a key source for this review. Lastly, the
most recent guidelines on the management of SAH and
their reference lists were also consulted and used to
provide some of the clinical recommendations [2-4].ed Central Ltd. The licensee has exclusive rights to distribute this article, in any
n. After this time, the article is available under the terms of the Creative Commons
/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction
roperly credited. The Creative Commons Public Domain Dedication waiver
/1.0/) applies to the data made available in this article, unless otherwise stated.
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Headache is a common complaint, accounting for 2% of
emergency department (ED) visits [5]. Although SAH
represents a very small percentage of those patients
admitted to the ED, it is a life-threatening condition that
needs to be recognised and treated immediately. Failure
to diagnose and treat SAH can lead to dire complications
including aneurysm rebleeding, cerebral infarction, and
ultimately death [6].
Misdiagnosis, defined as the failure to correctly recog-
nise SAH at first contact between a patient and a medical
professional, continues to occur and is associated with
increased mortality and morbidity. In a large cohort of
482 SAH patients admitted to a tertiary university hos-
pital, 12% of the cases were misdiagnosed according to the
above definition [6]. The likelihood of a missed diagnosis
was higher in patients with normal mental status because
their symptoms could be misattributed to conditions such
as migraine or tension headache, and less commonly to a
viral syndrome, musculoskeletal pain, sinusitis, and hyper-
tension [6]. Hence, it is not only imperative to have timely
diagnosis, but also to employ the most appropriate
and sensitive diagnostic modalities at first consultation
in the ED.
The most common diagnostic error is the lack of non-
contrast computed tomography (NCCT) ordered by the
ED physician [6]. NCCT remains the first-line method
for the diagnosis of SAH [3]. Evolving technology has
rapidly improved the new generations of multidetec-
tor computed tomography (CT) scanners, making this
equipment faster, less prone to motion artefacts, of
better resolution, and possessing more accurate tools. The
combination of this advanced technology with cutting-
edge post-acquisition image processing software makes
CT scanners more sensitive to detect subarachnoid blood.
Additionally, CT is also highly available and affordable,
making it the ideal screening modality for patients with
suspected SAH.
In a retrospective study using a four-slice, four-detector
CT scanner, Byyny and colleagues identified 149 patients
with spontaneous SAH who presented to an academic
tertiary care ED from 2001 to 2004 [7]. The sensitivity of
NCCT for SAH was found to range from 90 to 95%, caus-
ing the authors to conclude that NCCT has high sensitiv-
ity but should not be applied as a sole diagnostic modality
in the diagnosis of SAH. Moreover, NCCT sensitivity de-
creases with time since haemorrhage; it has close to 100%
sensitivity within 12 hours, 93% within 1 day, and less
than 60% within 1 week of haemorrhage [8].
A prospective, multicenter study included 11 tertiary
EDs from 2000 to 2009 [9]. Using a third-generation CT
scanner and imaging interpretation by an experienced
neuroradiologist, the group enrolled 3,132 patients who
were complaining of having ‘the worst headache of theirlives’, of which 240 (7.7%) had SAH. Although the overall
sensitivity for SAH was only 92.9% (95% confidence
interval (CI), 89.0 to 95.5%), all patients suffering from
SAH were identified in the subgroup of 953 patients who
were scanned within 6 hours of headache onset, thereby
yielding sensitivity of 100% (95% CI, 97.0 to 100.0%), spe-
cificity of 100% (95% CI, 99.5 to 100%), negative predictive
value of 100% (95% CI, 99.5 to 100%) and positive pre-
dictive value of 100% (95% CI, 96.9 to 100%). Additionally,
in a retrospective study conducted in an academic Level 1
trauma centre, among the 177 patients who presented
to the ED with headache and were scanned with a fifth-
generation CT scanner followed by a lumbar puncture
(LP), no patients with negative NCCT results were diag-
nosed with SAH on LP [10].
Three possible pathways for the diagnosis of SAH have
been described (Figure 1). Although the most invasive,
NCCT followed by LP is the most validated pathway to
rule out SAH [11]. NCCT combined with LP for patients
with high clinical suspicion of SAH have close to 100%
diagnostic sensitivity (95% CI, 93.1 to 99.4%) [10,12].
Ideally, cerebrospinal fluid analysis should be performed
using spectrophotometry, which has the highest diagnostic
accuracy among all cerebrospinal fluid analytical methods;
however, this technique is not widely available [13].
The second described approach is the use of NCCT
followed by computed tomography angiography (CTA).
Some studies showed that negative CTA can rule out
aneurysmal SAH in patients with severe headache and
negative NCCT or perimesencephalic haemorrhage pat-
tern [14,15]. The main disadvantages of this approach
are the need for iodinated contrast and its potential for
anaphylactic reaction and nephrotoxicity, but most im-
portantly exposure to radiation.
The third approach is the use of magnetic resonance
imaging (MRI) combined with magnetic resonance angi-
ography (MRA). The fluid-attenuated inversion recovery
MRI sequence is comparable with NCCT in detecting
acute SAH, and is clearly superior for subacute and chronic
haemorrhage [16]. MRI is also a powerful tool in the dif-
ferential diagnosis of intracranial pathologies, including
tumours, inflammatory, and infectious processes.
In conclusion, negative NCCT might be enough to
rule out SAH in patients presenting within 6 hours of
headache onset. Patients presenting beyond the 6-hour
mark require additional diagnostic testing if NCCT is
negative [3,4].
Diagnosis of cerebral aneurysms
Sensitivity and specificity for the detection of aneu-
rysms >3 mm using CTA currently approach 100%, and
are comparable with digital subtraction angiography (DSA)
[17-20]. Conventional CTA might be less sensitive and ac-
curate than DSA for aneurysms <3 mm. However, recent
Figure 1 Diagnostic approach for subarachnoid haemorrhage in patients presenting with more than 6 hours of headache onset. CTA,
computed tomography angiography; DSA, digital subtraction angiography; LP, lumbar puncture; MRA, magnetic resonance angiography; MRI,
magnetic resonance imaging; NCCT, noncontrast computed tomography; OR, operating room.
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scanner (sensitivity, specificity, and accuracy 96.3%, 100%,
and 98.5%, respectively) [21] and subtraction CTA perfor-
med in a 320-detector row scanner (sensitivity, speci-
ficity, and accuracy 81.8%, 100%, and 93.3%, respectively)
are highly accurate techniques to detect even aneu-
rysms <3 mm [22].
The high spatial and temporal resolution of DSA estab-
lished this modality as the gold standard for cerebral
aneurysm detection. However, DSA is invasive, costly,
time-consuming, and demands expertise, limiting its use
to a certain pool of medical professionals [23]. CTA may
serve as an excellent alternative [2]. Two recent high-
quality meta-analyses (Additional file 1: Table S2) [19,20]
found CTA to be highly accurate (97.2% sensitivity and
97.9% specificity) in diagnosing cerebral aneurysms when
compared with DSA.
DSA may still be required for treatment planning in
complex aneurysms that include branching points of
large vessels. However, modern CTA techniques, including
subtraction CTA and three-dimensional reconstructions,
can provide appropriate imaging even in complex cases
(Figure 2). DSA is definitely required in patients with
diffuse nonperimesencephalic SAH and negative initial
CTA. In this specific situation, DSA should be performed
to rule out small aneurysms [7,14], and may be repeated
within 2 to 6 weeks if the initial DSA is negative [24].
MRA is a possible alternative to CTA or DSA for
aneurysm detection, especially in patients with iodine
allergy. This modality does not expose the patients to
radiation, and does not necessarily require gadolinium
contrast injection. A recent published high-quality meta-
analysis (Additional file 1: Table S2) including 12 studies(960 patients assessed, 772 aneurysms) compared MRA
with DSA as the gold standard for aneurysm detection.
Most studies used time-of-flight sequences, which do not
require contrast. The pooled MRA sensitivity and speci-
ficity were 95% (95% CI, 89 to 98%) and 89% (95% CI, 80
to 95%), respectively [25]. The main disadvantages of this
modality are availability, costs, and the time consumed to
acquire the images.
Angiographic vasospasm and delayed cerebral
ischaemia
ACV is the narrowing of intracranial arteries detected by
vascular imaging, while DCI is a syndrome defined as a
focal neurological impairment, a decrease of at least 2
points on the Glasgow Coma Scale, or an increase of
two points on the National Institutes of Health Stroke
Scale that is not explained by other causes, such as hydro-
cephalus, rebleeding, or medical complications [26,27].
DCI is associated with higher rates of cerebral infarc-
tion, poor neurological outcome, and increased mortal-
ity [3,4,28,29].
Historically, DCI occurring within 2 weeks of aneurysm
rupture has been attributed to ACV. However, one-half of
the patients with severe ACV (>50% decrease in vessel
diameter) will not develop DCI and up to 20% of patients
without ACV (0 to 25% decrease in vessel diameter)
will develop symptoms, which suggests that other fac-
tors besides ACV must play a role in the aetiology of
DCI [30,31].
Transcranial Doppler ultrasonography
Transcranial Doppler ultrasonography (TCD) is a non-
invasive, reproducible, widely available technique that is
Figure 2 Computed tomography angiography and digital subtraction angiography. (A) to (C) Computed tomography angiography. (D) to
(F) Digital subtraction angiography. Red arrow, right terminal internal carotid artery aneurysm. (A), (D) Coronal view. (B), (E) Sagittal view. (C), (F)
Three-dimensional rendering.
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[3,32,33]. This technique is based on the principle that
the velocity of blood in a given artery is inversely pro-
portional to the cross-sectional area of the artery. The
mean middle cerebral artery (MCA) flow velocity is dir-
ectly correlated to the degree of ACV by DSA [34]
(Tables 1 and 2). A mean MCA flow velocity ≥120 cm/
second or an increase ≥50 cm/second over a 24-hour
period is consistent with ACV, and a mean MCA flow vel-
ocity ≥200 cm/second is diagnostic of severe ACV [13,33].
The Lindegaard ratio (the ratio of MCA to extracranial
portion of internal carotid artery mean flow velocity) is a
useful way to differentiate ACV from cerebral hyperaemia
(Table 2). Lindegaard ratio <3 is considered normal, while
a ratio ≥6 indicates severe ACV [33].
Several limitations of this technique should be men-
tioned: TCD is time consuming, is highly operator de-
pendent, and requires experienced personnel to ensure
consistent recordings. Up to 10% of patients, especially
older women, do not demonstrate adequate acoustic
windows [33]. More importantly, the accuracy for arteries
other than the MCA is very poor. A high-quality meta-
analysis [34] and a consensus statement [33] suggested
that TCD is a useful tool to rule in vasospasm in the
MCA, with high specificity and positive predictive value
of 99% and 97%, respectively. Other studies have reported
high specificity (94 to 100%) and variable sensitivity (39 to
96%) when TCD was compared to DSA in the MCA [33].
Negative results should be interpreted with caution be-
cause they may represent a false negative result. Transcra-
nial Doppler assessment of arteries other than the MCAis less useful, because of the low sensitivity and specifi-
city [32].
Multimodal computed tomography (NCCT + CTA +
computed tomography perfusion)
DCI is an exclusion diagnosis and can only be confirmed
by imaging. Multimodal CT is frequently applied as a dif-
ferential diagnostic tool at the moment of delayed neu-
rological deterioration. NCCT is useful to exclude other
causes of delayed neurological deterioration, such as
hydrocephalus, rebleeding, or cerebral oedema. CTA is a
good non-invasive alternative to DSA for diagnosing ACV
(Figure 5A) [32]. Both techniques have a high degree of
correlation for proximal ACV (agreement between 92 and
95%) [35,36]. However, the ability to monitor regional
cerebral blood flow (CBF) and to assess global and regional
cerebral perfusion is the main recent advance in DCI mon-
itoring. Computed tomography perfusion (CTP) can be
performed as a component of multimodal CT scanning
(Figure 5B, C). The combination of CTA/CTP is more
sensitive for ACV than TCD [33] and DSA [37].
Two high-quality meta-analyses that were recently
published included 15 studies with 915 patients [38,39].
The first meta-analysis included studies that defined
DCI as: clinical deterioration not explained by other
causes; cerebral infarction on follow-up CT or MRI; and
functional disability related to DCI. The results showed
that SAH patients with perfusion changes measured by
CTP had 23 times higher odds of having DCI than patients
with normal CTP parameters (odds ratio, 23.14; 95% CI,
5.87 to 91.19). The pooled sensitivity and specificity of
Figure 3 Technical aspects. Transcranial Doppler ultrasonography
(TCD) probe emits low-frequency (2 MHz), pulsed waves that cross
the skull at specific points called acoustic windows. The emitted
waves are reflected back from the moving red blood cells at an
altered frequency fe. The Doppler effect (fe) is the difference in
frequency between the transmitted wave f0 and the received wave
fe: fd = fe – f0. The red blood cells’ velocity can then be calculated
according to the following mathematic equation: V = c × fd / 2 ×
f0 × cosθ. θ is the angle formed by the ultrasound beam and the
blood flow. Ideally this angle should approach 0° so that the ultrasound
beam is parallel to the blood flow (cos0° = 1). The higher this angle, the
lower the velocity read by the machine. If the ultrasound beam is
perpendicular to the blood flow, no velocity will be detected
(cos90° = 0). This concept is fundamental to the performance and
interpretation of TCD results. The velocities can be underestimated,
never overestimated.
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(95% CI, 0.66 to 0.82), respectively [40-45].
The second meta-analysis included original prospective
and retrospective articles that reported data on the rela-
tionship between DCI (defined by clinical symptoms) and
CTP. Perfusion parameters (CBF, mean transit time, time
to peak, cerebral blood volume) were measured by either
a quantitative method (comparing perfusion parameters
in a given part of the brain with the same contralateralarea) or a qualitative method (visual inspection of affected
hemisphere compared with the contralateral side). The
included studies were divided into two categories: CTP
performed within 72 hours of haemorrhage (CTP as a
predictor of DCI), and CTP performed between days 4
and 14 after SAH (CTP as a diagnostic tool for DCI).
Early CTP parameters (<72 hours of SAH) were not
predictive of DCI, but an increased mean transit time
(pooled mean difference, 1.5 seconds; 95% CI, 0.9 to 2.2)
or decreased CBF (difference, −11.9 ml/100 g/minute;
95% CI, −15.2 to −8.6) in the CTP performed between day
4 and day 14 was diagnostic for DCI [41,44,46-54].
In summary, the use of multimodal CT may be useful in
the differential diagnosis of delayed neurological deterior-
ation. Mean transit time and CBF values can distinguish
between patients with and without DCI. However, the
absolute thresholds may differ depending on the scanner
and the post-processing methods applied.
Short-term and long-term follow-up imaging after
aneurysm treatment
Intraoperative angiography
Perioperative imaging is useful to detect complications
during and immediately after surgical clipping. Tang and
colleagues evaluated the use of intraoperative angiog-
raphy (IOA) performed during 517 consecutive cranioto-
mies for aneurysm clipping [55]. In 12.4% of the cases,
IOA findings resulted in surgical treatment change. Re-
sidual aneurysm (47%) and vessel flow compromise (44%)
were the two most common causes of treatment change
prompted by IOA. Aneurysms located in the internal ca-
rotid artery or giant aneurysms (>24 mm) were the two
factors independently associated with treatment revision.
Other case series have described similar results [56].
Long-term follow-up
The international SAH trial of neurosurgical clipping
versus endovascular coiling (International Subarachnoid
Aneurysm Trial) followed patients with SAH for a mean
period of 9 years after treatment [57]. Patients treated by
endovascular coiling have a 23% relative risk reduction
and a 7.4% absolute risk reduction in death and depend-
ence [58]; however, this is at a cost of significantly higher
rates of rebleeding (2.5% vs. 1%) and a need for late
retreatment (6.9 times higher rate) [59]. The main deter-
minant of postoperative rebleeding risk is whether or
not the aneurysm is completely excluded from the cere-
bral circulation (Figure 6).
After endovascular treatment, the mean time to late
retreatment (that is, >3 months after coiling or 1 month
after clipping) was 20.7 months (range, 3 to 80 months)
versus 5.7 months in the clipped group. Younger patients
(<40 years old), larger aneurysms (≥11 mm), and incom-
plete occlusion (Additional file 1: Table S3) are the main
Figure 4 Effect of the angle between the ultrasound beam and blood flow. (1) Ultrasound beam is parallel to blood flow, acquiring an
optimal, high-frequency Doppler signal. (2) Ultrasound beam forms an angle <20°, leading to a good signal. (3) Ultrasound beam is almost at 90°,
resulting in a damped waveform. (4) Blood flow direction is away from ultrasound beam, which results in a negative Doppler signal.
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term follow-up imaging is therefore usually required to
detect aneurysm recurrences, especially after coiling [59].
MRA may be an attractive alternative to DSA in the
setting of post-coiling follow-up (Figure 7). MRA is non-
invasive, usually does not require contrast, and does not
expose the patient to radiation.
van Amerongen and colleagues performed a high-
quality systematic review and meta-analysis of 26 studies
comparing MRA with DSA for follow-up of coiled aneu-
rysms [61]. Both time-of-flight and contrast-enhanced
MRA were highly accurate. The pooled time-of-flight
MRA sensitivity and specificity were 86% and 84%, re-
spectively; similarly contrast-enhanced MRA had 86%
sensitivity and 89% specificity.
Even though aneurysm recurrence after clipping is less
frequent, imaging follow-up is still required. Multiple
studies comparing postoperative CTA versus DSA have
been published with similar results [62-68]. Multidetector
CTA is highly sensitive and specific for residual aneurysm
detection and parent vessel occlusion, and might be a
valuable diagnostic alternative to DSA. However, DSATable 1 Transcranial Doppler characteristics
Artery Window Depth (mm)
Middle cerebral Temporal 40 to 60
Anterior cerebral Temporal 60 to 85
Posterior cerebral Temporal 60 to 70
Extracranial internal carotid Submandibular 50
Vertebral Occipital 60 to 80
Basilar Occipital 80 to 120might still be required for aneurysm with multiple clips
[67,69], for neck remnant detection [68], or for aneurysms
located in the posterior circulation [63].
The main concern with the use of postoperative CTA
for aneurysm follow-up is the image quality, which can
be compromised by clip-generated artefacts (Figure 5F)
[64]. The factors associated with CTA image quality in-
clude the clip material (cobalt is worse than titanium
alloy clips) [69,70], clip orientation (within the scan
plane), and the number of clips on the same aneurysm
[64,69]. Metal artefact reduction algorithms using flat-
panel detector CT [71,72], subtraction three-dimensional
CTA with the orbital synchronised helical scan technique
[65], and advanced 3 T MRI imaging techniques [73] are
some of the new modalities applied to reduce artefacts
generated by the metallic clips, which can in turn improve
the quality of the image.
In summary, patients treated by either surgical clipping
or endovascular coiling should be followed after aneurysm
occlusion [59]. Ideally, IOA should be performed to detect
complications during surgical clipping. After endovascular
coiling, the postoperative surveillance by either DSA orDirection of flow Mean flow velocity (cm/second)
Toward probe 55 ± 12
Away from probe 50 ± 11
Toward 40 ± 10
Away 28 ± 17
Away 38 ± 10
Away 41 ± 10
Table 2 Middle cerebral artery criteria of angiographic





Normal values 35 to 89 <3
Above normal values 90 to 119 –
Mild vasospasm 120 to 150 3 to 4
Moderate 150 to 199 4 to 5.9
Severe ≥200 ≥6
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or contrast-enhanced sequences may be the modality of
choice. Clipped aneurysms can be followed by the use of
CTA, but DSA should be performed if clip artefacts pre-
vent adequate image interpretation. The time interval be-
tween images and duration of follow-up remain unclear.
Future directions
Several emerging imaging modalities are currently avail-
able for research purposes, such as magnetic resonance-
based images (including functional MRI) and positronFigure 5 Multimodal computed tomography. (A) Computed tomograp
vasospasm in the left middle cerebral artery (MCA; red arrow). (B) CT perfu
the left hemisphere) due to MCA vasospasm. (C) Same patient, CT perfusio
shows resolution of perfusion changes. (D) Noncontrast computed tomogr
proposed by van Gijn and colleagues [98]. (E) NCCT shows large volume o
ventriculostomy drains can be seen in the anterior horn of the lateral ventr
generated by the metallic colis.emission tomography (PET). In the near future, these
evolving fields of neuroimaging may serve as important
tools when choosing treatment options and predicting
functional and cognitive recovery after SAH.
Magnetic resonance-based modalities
Structural magnetic resonance imaging
Structural damage caused by the primary haemorrhage,
treatment, or DCI is not infrequent after SAH, and can
ultimately lead to neuropsychological deficits and cogni-
tive impairment. MRI can identify these structural changes
[74,75]. Parenchymal high-signal intensity lesions detected
on T2-weighted and intermediate-weighted images, and
low signal intensity on three-dimensional T1-weighted
images can represent a variety of aetiologies such as is-
chaemic lesions, residual haematoma, retraction injury
due to surgical manipulation and instrumentation, lesions
associated with external ventricular drains (Figure 5E)
or permanent shunt placement, and previous infarctions.
These high-signal intensity lesions are more frequent after
surgical clipping and the lesion volume correlates with
neuropsychological test performance [76].hy (CT) angiography (coronal plane) shows severe angiographic
sion displays increased mean transit time (increased shades of red in
n repeated after 48 hours of haemodynamic augmentation, which
aphy (NCCT) showing the measurement of bicaudate index (A/B) as
f intraventricular haemorrhage. The tip of the bilateral external
icles (blue arrows). (F) NCCT quality severely compromised by artefacts
Figure 6 Digital subtraction angiography. (A) Selective left vertebral artery injection shows a basilar tip aneurysm (red arrow). (B) The same
basilar tip aneurysm (white arrow), now appreciated through a three-dimensional rendering. (C) The gray structure is the mass of coils packing
the previous basilar tip aneurysm. Final results show a complete obliteration of the aneurysm’s sac after the endovascular coiling.
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The measurement of temporomesial volume by volumet-
ric MRI (the protocol includes T2-weighted and proton
density-weighted images, MRA, and three-dimensional
T1-weighted sequences) [77], especially the hippocampal
formation, can provide important information on cogni-
tive performance [78]. Lesions affecting the bilateral
medial temporal lobes typically lead to severe memory
deficits. Unilateral lesions in the dominant hemisphere
can cause deficits in verbal memory, while unilateral
lesions in the nondominant hemisphere can cause vis-
ual–spatial memory loss. Aneurysmal SAH was shown
to be associated with temporomesial atrophy, especially
after surgical clipping [76]. Temporomesial volume loss
is correlated with neuropsychological impairment, which
includes memory deficits [78].
Bendel and colleagues examined the impact of brain
structure volume changes on neurocognitive performance
by evaluating the MRI scans of 138 patients that were ran-
domly assigned to surgical versus endovascular treatment
1 year after the haemorrhage. Reduced hippocampal
volume correlated with poor score on several measures of
cognitive function such as visual memory, attention, flexi-
bility of mental processing, intellectual ability, and psycho-
motor speed [78]. These deficits are more pronounced in
patients who have combined decreased hippocampal vol-
ume and frontal lobe lesions, and are more common after
surgical clipping than endovascular coiling [79].The same group described the relationship of global
cerebral atrophy and cognitive deficit after SAH [80].
Seventy-six patients (1 year after haemorrhage) and 30
healthy controls underwent MRI (T2-weighted and proton
attenuation-weighted images, and three-dimensional
T1-weighted images needed for volumetry). The cerebro-
spinal fluid/total intracranial volume ratio was quantified
by statistical parametrical mapping, and was statisti-
cally higher in SAH patients and correlated with clinical
outcome (that is, Glasgow outcome scale) and cognitive
deficit.
Diffusion-weighted imaging
Diffusion-weighted imaging identifies tissues at risk for
ischaemia by detecting restriction to water diffusion.
Diffusion-weighted imaging is a potent instrument for
the detection of early brain injury after SAH [81], pre-
senting higher sensitivity compared to NCCT [82,83].
Diffusion-weighted imaging may predict functional out-
come after poor-grade SAH [84,85]. In a very elegant
study, Sato and colleagues included 38 poor-grade SAH
patients that were treated aggressively. Lesions >10 mm
on diffusion-weighted imaging scans performed within
24 hours of haemorrhage were predictive of poor out-
come (severe disability, vegetative state or death). The
authors attributed these lesions to primary brain damage
(that is, haemorrhage) [84]. This hypothesis of early brain
ischaemia has been supported by recent work that showed
Figure 7 Magnetic resonance angiography. (A) Contrast-enhanced (CE) magnetic resonance angiography (MRA) sequence showing recanalisation
of a previously coiled basilar tip aneurysm (large white arrow). (B) Time-of-flight MRA sequence revealing the refilling of the same basilar tip aneurysm
(small white arrow). (C) CE-MRA and (D) time-of-flight MRA sequences after retreatment. No additional filling of the aneurysm is seen (red arrows).
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aging/apparent diffusion coefficient correlated with death
or severe disability (adjusted odds ratio, 1.7; 95% CI, 1.0 to
3.2; P = 0.066) [86].
Functional magnetic resonance imaging
Functional MRI is a neuroimaging modality that mea-
sures brain activity by detecting changes in CBF. The
modality was first described by Seiji Ogawa, using what
he called blood oxygen level-dependent contrast [87].
This technique assumes that CBF is coupled with neuronal
activation; therefore, CBF increases towards a given brain
region that is in use.
Functional MRI represents a possible step towards our
capability of prognosticating patients suffering from acute
brain injury, including ischaemic stroke [88], intracerebral
haemorrhage [89], and SAH [90]. This modality has a po-
tential advantage over structural modalities by being ableto assess brain function in real time. However, its use
remains largely experimental.
The functional MRI literature in the SAH population
is very scant. In a single prospective study, 11 SAH
patients and 10 healthy subjects underwent functional
MRI while performing verbal working memory tasks. Pa-
tients performed worse than healthy individuals (percent
correct 82.9% vs. 97.5%, P <0.003). The memory impair-
ment was accompanied by a relatively increased blood
oxygen level-dependent signal in widespread bilateral cor-
tical areas. The authors hypothesised that ‘deficits in verbal
working memory following recovery from SAH are accom-
panied by widespread differences in hemodynamic corre-
lates of neural activity. These differences are discussed with
respect to the immediate and delayed focal and global brain
damage that can occur following SAH, and the possibility
that this damage induces subcortical disconnection and
subsequent decreased efficiency in neural processing’ [90].
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PET is a modality that maps perfusion and physiological
activity by the use of exogenous radioactive compounds
that are injected systemically. PET records and interpolates
anatomical regions of the brain through detection of elec-
tromagnetic radiation; it also measures global and regional
CBF, and also the oxygen delivery to cerebral tissues, which
are important endpoints for DCI monitoring [91-94].
Over the last decade, a group from the Washington
University School of Medicine led by Dr Diringer has
conducted a series of experiments to determine the opti-
mal haemodynamic intervention that would improve
cerebral oxygen delivery in a setting of DCI. In the first
experiment, the authors examined the effects of a normal
saline fluid bolus on regional and global CBF, measured by
PET. Six SAH patients who developed DCI underwent
PET scanning before and after a normal saline bolus of
15 ml/kg administered over 1 hour. The fluid bolus was
associated with increased CBF in hypoperfused regions of
the brain [95]. In the second experiment, eight anaemic
(<10 g/dl) SAH patients underwent PET scanning before
and after the transfusion of 1 unit of red blood cells. Blood
transfusion was associated with increased cerebral oxygen
delivery in areas of ischaemia, reduction of oxygen extrac-
tion fraction, and no change in global CBF [96].
In the last published experiment, the authors compared
the effect of a saline fluid bolus of 15 ml/kg, of induced
hypertension by increasing mean arterial pressure by 25%,
and of the transfusion of 1 unit of red blood cells [97].
Regional and global CBF, as well as oxygen delivery, were
measured by PET imaging in 38 SAH patients that devel-
oped DCI. All three methods increased regional oxygen
delivery from baseline, but red blood cell transfusion
to anaemic patients (haemoglobin <9.0 g/dl) performed
better than both hypertension and volume loading as a
haemodynamic intervention in reducing the ischaemic
burden.
Despite the interesting conclusions drawn from those
studies, the utility of PET remains limited to research.
The required isotopes are very expensive and restricted
to major centres, thus limiting the technique’s clinical
applications.
Conclusion
Neuroimaging is a fundamental component in the man-
agement of patients suffering from SAH. NCCT might
be sufficient to rule out SAH if performed within 6 hours
of headache onset. However, patients presenting beyond
the 6-hour mark with symptoms suspicious for SAH and
negative NCCT should undergo LP. The combinations
of NCCT and CTA or MRI and MRA are at least as
sensible as the classic NCCT and LP approach, and can
be used to rule out SAH. CTA is slowly replacing DSA
as the first-line technique for the diagnosis and treatmentplanning of cerebral aneurysms, but DSA is still required
in patients with diffuse SAH and initially negative CTA.
The modern concept of DCI monitoring is shifting from
modalities used to detect angiographic vasospasm to tech-
niques focusing on brain perfusion, such as CTP. Lastly,
new modalities applied to assess cerebral physiological,
functional, and cognitive outcome after SAH are rapidly
evolving; however, their use remains experimental.
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